Kyler Zeleny
UCLA researchers are restarting a study to give a gene therapy to kids with an ultra-rare disease. While the one-time therapy is safe and effective, the drug industry has been uninterested. The treatment is complex and costly, and the number of patients with SCID is tiny, limiting profits.Researchers are now restarting a clinical trial to treat children with a severe...